1. Home
  2. NAMS vs BNL Comparison

NAMS vs BNL Comparison

Compare NAMS & BNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • BNL
  • Stock Information
  • Founded
  • NAMS 2019
  • BNL 2007
  • Country
  • NAMS Netherlands
  • BNL United States
  • Employees
  • NAMS N/A
  • BNL N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • BNL Real Estate Investment Trusts
  • Sector
  • NAMS Health Care
  • BNL Real Estate
  • Exchange
  • NAMS Nasdaq
  • BNL Nasdaq
  • Market Cap
  • NAMS 2.7B
  • BNL 3.0B
  • IPO Year
  • NAMS N/A
  • BNL 2020
  • Fundamental
  • Price
  • NAMS $23.33
  • BNL $15.78
  • Analyst Decision
  • NAMS Strong Buy
  • BNL Hold
  • Analyst Count
  • NAMS 7
  • BNL 7
  • Target Price
  • NAMS $38.17
  • BNL $18.60
  • AVG Volume (30 Days)
  • NAMS 538.3K
  • BNL 1.0M
  • Earning Date
  • NAMS 02-06-2025
  • BNL 02-19-2025
  • Dividend Yield
  • NAMS N/A
  • BNL 7.27%
  • EPS Growth
  • NAMS N/A
  • BNL N/A
  • EPS
  • NAMS N/A
  • BNL 0.75
  • Revenue
  • NAMS $33,594,000.00
  • BNL $424,671,000.00
  • Revenue This Year
  • NAMS $131.53
  • BNL N/A
  • Revenue Next Year
  • NAMS N/A
  • BNL $4.46
  • P/E Ratio
  • NAMS N/A
  • BNL $21.18
  • Revenue Growth
  • NAMS 78.77
  • BNL N/A
  • 52 Week Low
  • NAMS $15.19
  • BNL $14.21
  • 52 Week High
  • NAMS $27.29
  • BNL $19.15
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 44.28
  • BNL 44.28
  • Support Level
  • NAMS $23.17
  • BNL $15.02
  • Resistance Level
  • NAMS $26.71
  • BNL $16.04
  • Average True Range (ATR)
  • NAMS 0.94
  • BNL 0.25
  • MACD
  • NAMS -0.40
  • BNL 0.09
  • Stochastic Oscillator
  • NAMS 23.65
  • BNL 76.32

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About BNL Broadstone Net Lease Inc.

Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.

Share on Social Networks: